Josef Vormoor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Josef Vormoor has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Andrew G. Hall
Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK
1 shared publicationDaniel Williamson
Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK
1 shared publication- Deepali Pal
Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom
1 shared publication Julie Irving
Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK
1 shared publicationKerrie Wilson
Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK
1 shared publicationKlaus Rehe
Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK
1 shared publication
Latest Publications
- 1 December 2016
- Published by Elsevier in Cancer Cell
- Vol. 30 (6) , 825-826
Dormancy Stems the Tide of Chemotherapy
- 1 December 2016
- Published by Elsevier in Cancer Cell
- Vol. 30 (6) , 825-826
Dormancy Stems the Tide of Chemotherapy
- Open Access
- 11 December 2012
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 5 (1) , 38-51
Acute B lymphoblastic leukaemia‐propagating cells are present at high frequency in diverse lymphoblast populations
Leukaemia‐propagating cells are more frequent in high‐risk acute B lymphoblastic leukaemia than in many malignancies that follow a hierarchical cancer stem cell model. It is unclear whether this characteristic can be more universally applied to patients from non‐‘high‐risk’ sub‐groups and across a broad range of cellular immunophenotypes. Here, we demonstrate in a wide range of primary patient samples and patient samples previously passaged through mice that leukaemia‐propagating cells are found in all populations defined by high or low expression of the lymphoid differentiation markers CD10, CD20 or CD34. The frequency of leukaemia‐propagating cells and their engraftment kinetics do not differ between these populations. Transcriptomic analysis of CD34 high and CD34 low blasts establishes their difference and their similarity to comparable normal progenitors at different stages of B‐cell development. However, consistent with the functional similarity of these populations, expression signatures characteristic of leukaemia propagating cells in acute myeloid leukaemia fail to distinguish between the different populations. Together, these findings suggest that there is no stem cell hierarchy in acute B lymphoblastic leukaemia. →See accompanying article 10.1002/emmm.201202207
- 11 December 2012
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 5 (1) , 38-51
Open AccessAcute B lymphoblastic leukaemia‐propagating cells are present at high frequency in diverse lymphoblast populations
Leukaemia‐propagating cells are more frequent in high‐risk acute B lymphoblastic leukaemia than in many malignancies that follow a hierarchical cancer stem cell model. It is unclear whether this characteristic can be more universally applied to patients from non‐‘high‐risk’ sub‐groups and across a broad range of cellular immunophenotypes. Here, we demonstrate in a wide range of primary patient samples and patient samples previously passaged through mice that leukaemia‐propagating cells are found in all populations defined by high or low expression of the lymphoid differentiation markers CD10, CD20 or CD34. The frequency of leukaemia‐propagating cells and their engraftment kinetics do not differ between these populations. Transcriptomic analysis of CD34 high and CD34 low blasts establishes their difference and their similarity to comparable normal progenitors at different stages of B‐cell development. However, consistent with the functional similarity of these populations, expression signatures characteristic of leukaemia propagating cells in acute myeloid leukaemia fail to distinguish between the different populations. Together, these findings suggest that there is no stem cell hierarchy in acute B lymphoblastic leukaemia. →See accompanying article 10.1002/emmm.201202207